Full-Time

Senior Manager Regulatory CMC

Posted on 9/25/2024

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$128k - $160.2kAnnually

+ Bonus + Equity Awards

Senior

San Diego, CA, USA

Hybrid model requires in-office presence three days per week on average.

Category
Risk & Compliance
Legal & Compliance
Requirements
  • Bachelor’s degree in a life science or related field.
  • Targeting at least 7 years of progressively responsible experience in CMC Regulatory Affairs with a focus on small molecule drug development.
  • Knowledge and understanding of global regulatory CMC requirements and guidelines.
  • Previous experience in the preparation and submission of the CMC components of IND/CTA and NDA and ex-US MAA submissions.
  • Ability to work in a cross-functional team environment and manage competing priorities.
  • Strong interpersonal skill, attention to detail and excellent organizational, computer, and documentation skills.
  • Ability to meet deadlines and perform multiple tasks in a fast paced setting.
  • Demonstrated personal initiative, responsibility, flexibility, the ability to work under limited supervision, and ability to handle multiple project assignments.
  • Skilled at negotiating with/influencing business partners and departmental leaders regarding matters of significance to the department or segments of the organization.
  • Adept at communicating a clear vision among team members effectively aligning resources to achieve functional area goals.
Responsibilities
  • Supports CMC regulatory affairs activities for marketed products and compounds in development in line with US and ex-US regulatory requirements.
  • Coordinates with R&D, Pharmaceutical Development, Manufacturing, Quality and Regulatory colleagues and other functional areas to develop and implement CMC regulatory strategy.
  • Organizes and contributes to the timely preparation of high quality CMC sections of INDs/CTAs, NDAs, MAAs and amendments for submission to global regulatory authorities, supporting the conduct of clinical trials and marketing applications.
  • Contributes as a key regulatory representative with external parties for CMC development activities.
  • Interacts with regulatory agencies for CMC development activities as required.
  • Supports the regulatory function on development teams providing CMC regulatory guidance and strategy including identifying and assessing/mitigating regulatory risks.
  • Participates in ensuring compliance of CMC activities with applicable regulatory requirements.
  • Evaluates Manufacturing processes and changes, assesses the regulatory implications and supports their implementation.
  • Maintains current knowledge of the relevant guidelines and regulations and determine applicability to company activities.
  • Other duties as assigned.
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia received Health Canada approval for Daybue to treat Rett Syndrome.
  • The company entered an exclusive license agreement with Saniona for SAN711.
  • Acadia's collaboration with Ryan Reynolds raises awareness for Parkinson's disease.

What critics are saying

  • Regulatory approval processes can delay drug commercialization timelines.
  • High R&D costs may impact financial stability if drugs fail clinical trials.
  • Competition in the biopharmaceutical market is intense, affecting market share.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on small molecule drugs for central nervous system disorders.
  • Pimavanserin is being developed for multiple neurological and psychiatric indications.
  • Acadia has strategic partnerships, enhancing its research and market reach.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE